MONITORING OF CHIMERISM IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION BY QUANTITATIVE ASSESSMENT: THE BEST TOOL FOR MONITORING OF MINIMAL RESIDUAL DISEASE?

被引:0
|
作者
Bouvier, A. [1 ]
Thepot, S. [2 ]
Francois, S. [2 ]
Guardiola, P. [3 ]
Tanguy-Schmidt, A. [2 ]
Beucher, A. [1 ]
Genevieve, F. [1 ]
Hunault-Berger, M. [2 ]
Zandecki, M. [1 ]
Ifrah, N. [2 ]
Blanchet, O. [1 ]
机构
[1] CHU Angers, Hematol Lab, Angers, France
[2] CHU Angers, Serv Malad Sang, Angers, France
[3] CHU Angers, Plateforme STE, Angers, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PB1417
引用
收藏
页码:553 / 554
页数:2
相关论文
共 50 条
  • [1] Intensive monitoring of minimal residual disease and chimerism after allogeneic hematopoietic stem cell transplantation for acute leukemia in children
    Thomas Pincez
    Raoul Santiago
    Henrique Bittencourt
    Isabelle Louis
    Mélanie Bilodeau
    Alexandre Rouette
    Loubna Jouan
    Josette-Renée Landry
    Françoise Couture
    Johanne Richer
    Pierre Teira
    Michel Duval
    Sonia Cellot
    Bone Marrow Transplantation, 2021, 56 : 2981 - 2989
  • [2] Intensive monitoring of minimal residual disease and chimerism after allogeneic hematopoietic stem cell transplantation for acute leukemia in children
    Pincez, Thomas
    Santiago, Raoul
    Bittencourt, Henrique
    Louis, Isabelle
    Bilodeau, Melanie
    Rouette, Alexandre
    Jouan, Loubna
    Landry, Josette-Renee
    Couture, Francoise
    Richer, Johanne
    Teira, Pierre
    Duval, Michel
    Cellot, Sonia
    BONE MARROW TRANSPLANTATION, 2021, 56 (12) : 2981 - 2989
  • [3] Impact of Minimal Residual Disease and Chimerism Monitoring at Different Timepoints after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
    Martin-Rojas, Reyes Maria
    Oarbeascoa, Gillen
    Bailen, Rebeca
    Gomez-Centurion, Ignacio
    Juarez, Luis Miguel
    Dorado, Nieves
    Martinez-Laperche, Carolina
    Perez-Corral, Ana
    Buno, Ismael
    Anguita, Javier
    Diez-Martin, Jose L.
    Kwon, Mi
    BLOOD, 2020, 136
  • [4] Detection of Relapse after Hematopoietic Stem Cell Transplantation in Childhood By Monitoring of Minimal Residual Disease and Chimerism
    Gruhn, Bernd
    Sanft, Juliane
    Wolff, Ilona
    Beck, James F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S34 - S35
  • [5] Minimal residual disease monitoring is superior to chimerism assessment for relapse prediction in acute lymphoblastic leukemia after allogeneic stem cell transplantation
    Terwey, T. H.
    Hemmati, P. G.
    Nagy, M.
    Pfeifer, H.
    Goekbuget, N.
    Brueggemann, M.
    Le Duc, T. M.
    le Coutre, P.
    Doerken, B.
    Arnold, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 138 - 138
  • [6] Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia
    Candoni, Anna
    Tiribelli, Mario
    Toffoletti, Eleonora
    Cilloni, Daniela
    Chiarvesio, Alexia
    Michelutti, Angela
    Simeone, Erica
    Pipan, Corrado
    Saglio, Giuseppe
    Fanin, Renato
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 82 (01) : 61 - 68
  • [7] Monitoring for Minimal Residual Disease before and after Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed Acute Leukemia
    Li, Weijing
    Li, Xiaofan
    Huang Jiafu
    Chen Yuanzhong
    Xu, Zhenshu
    Li, Nainong
    BLOOD, 2019, 134
  • [8] Minimal residual disease (MRD) monitoring after autologous stem cell transplantation (auSCT) in acute myeloid leukemia (AML).
    Venditti, A
    Buccisano, F
    Del Poeta, G
    Tamburini, A
    Maurillo, L
    Postorino, M
    Picardi, A
    Riccitelli, A
    Amadori, S
    BLOOD, 2000, 96 (11) : 311A - 311A
  • [9] Post Stem Cell Transplantation Monitoring in Acute Myeloid Leukemia by Markers of Minimal Residual Disease and Engraftment
    Kim, A. S.
    Kressin, M. K.
    Mosse, C. A.
    Seegmiller, A.
    LABORATORY INVESTIGATION, 2012, 92 : 347A - 347A
  • [10] Post Stem Cell Transplantation Monitoring in Acute Myeloid Leukemia by Markers of Minimal Residual Disease and Engraftment
    Kim, A. S.
    Kressin, M. K.
    Mosse, C. A.
    Seegmiller, A.
    MODERN PATHOLOGY, 2012, 25 : 347A - 347A